A brief question from friend and colleague Kirk Guyer, BioMedica Diagnostics, Inc: When a coag lab runs controls for DRVVRT, do they analyze the controls only based on clotting time or do they also use the ratio as a pass/fail criteria?
Apr 11, 2020 7:22pm
This is an "off-label" post, as it doesn't directly address hemostasis, however, on April 6, Ari Elman, MD, Hem-Onc at Greater Baltimore Medical Center wrote,
Apr 7, 2020 12:19pm
Please refer to our April 6, 2020 Covid discussion [click or tap] for a valuable 6 PM comment from Precision BioLogic friend and colleague, Ali Sadeghi-Khomami, who directs Precision's research team, Ali has provided valuable specimen management information.